Publications by authors named "Melissa Engle"

Claim this Profile
A
Author Correction: Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.
Vincent K Chang, Marjorie Z Imperial, Patrick P J Phillips, Gustavo E Velásquez, Payam Nahid, Melissa Engle

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes.
Ekaterina V Kurbatova, William C Whitworth, Lakshmi Praveena Peddareddy, Patrick P J Phillips, Nigel A Scott, Melissa Engle

Emerg Infect Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical Trial.
Ava Y Xu, Gustavo E Velásquez, Nan Zhang, Vincent K Chang, Patrick P J Phillips, Melissa L Engle

Am J Respir Crit Care Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.
Vincent K Chang, Marjorie Z Imperial, Patrick P J Phillips, Gustavo E Velásquez, Payam Nahid, Melissa Engle

Nat Commun· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.
Huy X Ngo, Ava Y Xu, Gustavo E Velásquez, Nan Zhang, Vincent K Chang, Melissa Engle

Clin Infect Dis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central monitoring in a randomized, open-label, controlled phase 3 clinical trial for a treatment-shortening regimen for pulmonary tuberculosis.
Kia E Bryant, Yan Yuan, Melissa Engle, Ekaterina V Kurbatova, Cynthia Allen-Blige

Contemp Clin Trials· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.
Susan E Dorman, Payam Nahid, Ekaterina V Kurbatova, Patrick P J Phillips, Kia Bryant, Melissa Engle

N Engl J Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased plasma rifapentine concentrations associated with AADAC single nucleotide polymorphism in adults with tuberculosis.
Marc Weiner, Jon Gelfond, Teresa L Johnson-Pais, Melissa Engle, John L Johnson

J Antimicrob Chemother· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial.
Susan E Dorman, Payam Nahid, Ekaterina V Kurbatova, Stefan V Goldberg, Lorna Bozeman, Melissa Engle

Contemp Clin Trials· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated Plasma Moxifloxacin Concentrations and g.-11187G>A Polymorphism in Adults with Pulmonary Tuberculosis.
Marc Weiner, Jon Gelfond, Teresa L Johnson-Pais, Melissa Engle, Charles A Peloquin

Antimicrob Agents Chemother· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood Transcriptional Biomarkers for Active Tuberculosis among Patients in the United States: a Case-Control Study with Systematic Cross-Classifier Evaluation.
Nicholas D Walter, Mikaela A Miller, Joshua Vasquez, Marc Weiner, Adam Chapman, Melissa Engle

J Clin Microbiol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rifapentine Pharmacokinetics and Tolerability in Children and Adults Treated Once Weekly With Rifapentine and Isoniazid for Latent Tuberculosis Infection.
Marc Weiner, Radojka M Savic, William R Mac Kenzie, Diane Wing, Charles A Peloquin, Melissa Engle

J Pediatric Infect Dis Soc· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis.
Payam Nahid, Erin Bliven-Sizemore, Leah G Jarlsberg, Mary A De Groote, John L Johnson, Melissa Engle

Tuberculosis (Edinb)· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic interaction of rifapentine and raltegravir in healthy volunteers.
Marc Weiner, Eric F Egelund, Melissa Engle, Melissa Kiser, Thomas J Prihoda

J Antimicrob Chemother· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of time to detection of Mycobacterium tuberculosis in broth culture as a determinant for end points in treatment trials.
Marc Weiner, Thomas J Prihoda, William Burman, John L Johnson, Stefan Goldberg, Melissa Engle

J Clin Microbiol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations.
Marc Weiner, Charles Peloquin, William Burman, Chi-Cheng Luo, Melissa Engle

Antimicrob Agents Chemother· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of rifampin and multidrug resistance gene polymorphism on concentrations of moxifloxacin.
Marc Weiner, William Burman, Chi-Cheng Luo, Charles A Peloquin, Melissa Engle

Antimicrob Agents Chemother· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection.
Debra A Benator, Marc H Weiner, William J Burman, Andrew A Vernon, Zhen A Zhao, Melissa Engle

Pharmacotherapy· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis.
William J Burman, Stefan Goldberg, John L Johnson, Grace Muzanye, Melissa Engle

Am J Respir Crit Care Med· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the drug interaction between rifabutin and efavirenz in patients with HIV infection and tuberculosis.
Marc Weiner, Debra Benator, Charles A Peloquin, William Burman, Andrew Vernon, Melissa Engle

Clin Infect Dis· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis